India to Colombia: Bevacizumab Export Trade Route

The India to Colombia Bevacizumab corridor is one of India's established pharmaceutical export routes, with 34 shipments documented worth a combined $3.7M USD. The route is dominated by DR.REDDY'S LABORATORIES LTD, which alone accounts for roughly 36% of all export value, reflecting the consolidated nature of India's bevacizumab manufacturing sector.

Across 5 active suppliers, the average shipment value stands at $109.4K USD — a figure that reflects both bulk commercial orders from large pharmaceutical companies and smaller specialty shipments. Freight is split between sea (65%) and air (15%), suggesting a mix of scheduled bulk orders and time-sensitive consignments.

Shipment activity peaks during April–June, with an average transit time of 17 days port-to-port. The route has recorded an annual growth rate of 17.1%, placing it at rank #3 among India's top bevacizumab export destinations globally.

On the import side, key buyers of Indian bevacizumab in Colombia include DR.REDDYS LABORATORIES SAS, DR.REDDYS LABORATORIES SAS , DRREDDYS LABORATORIES SAS and 3 others. DR.REDDYS LABORATORIES SAS is the single largest importer with 12 shipments valued at $1.0M USD.

India's bevacizumab exports to Colombia are driven primarily by a handful of large-scale manufacturers. DR.REDDY'S LABORATORIES LTD with 17 shipments leads the pack, a pattern common in generic pharmaceutical corridors where manufacturing scale creates significant cost advantages. The presence of 5 active exporters signals a competitive but concentrated market — buyers in Colombia benefit from supplier diversity while the top tier handles the majority of volume.

The top 3 suppliers — DR.REDDY'S LABORATORIES LTD, DR REDDYS LABORATORIES LIMITED, DR.REDDY'S LABORATORIES LTD — together account for 85% of total trade value on this route. The average shipment value of $109.4K USD reflects primarily bulk commercial orders from large pharmaceutical distributors.

Beyond the primary product category, shipments on this route include closely related formulations such as persivia 100mg/4ml 1sbevacizumabqty:4573 vials and persivia 100mg/4ml(bevacizumab)[1s](qty: , suggesting that buyers in Colombia tend to consolidate orders across related product lines from the same Indian supplier.

On the buying side, DR.REDDYS LABORATORIES SAS is the largest importer with 12 shipments worth $1.0M USD — representing 27% of all bevacizumab imports from India on this route. A total of 6 buyers are active on this corridor.